#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary adrenal insufficiency Exudative retinopathy Malignant oligodendroglioma Short-bowel syndrome Myotonia Hyperchylomicronaemia Fallopian tube cancer Proteus syndrome Congenital cystic kidney disease Sarcoma Kawasaki's disease Leiomyosarcoma Hypoxic-ischaemic encephalopathy Anal cancer recurrent Acute leukaemia More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Life with Disease Proteus syndrome – Basic Information Prader-Willi syndrome – Trials in Disease Von Willebrand’s disease – Life with Disease Anaplastic thyroid cancer – Basic Information Hepatic angiosarcoma – Life with Disease Inclusion body myositis – Life with Disease Atypical haemolytic uraemic syndrome – Treatment Behcet’s syndrome – Trials in Disease Hepatoblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olanzapine Dfv890 Atorvastatin Samuraciclib Octocog Alfa Roflumilast Ecopipam Hydrochloride Balstilimab Treprostinil Palmitil Venetoclax AZD0292 Burfiralimab Piritramide A/(H3N2)-LIKE VIRUS ANTIGEN Calcipotriol Nido-361 Iloprost Trometamol Gskvx000000009151 Iron Sucrose AZD5148 More therapies…

    Learn about Your Condition

    Primary amyloidosis Bladder cancer Procedural hypotension Brain abscess Obesity Cytomegalovirus infection Ischaemic stroke Pancreatitis relapsing Chronic fatigue syndrome Testicular germ cell cancer Intestinal obstruction Bronchopulmonary dysplasia Univentricular heart Type IIa hyperlipidaemia Renal cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cell Physiological Phenomena

  • Study of the effect of hyperbaric oxygen therapy on the bacteria in chronic wounds

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Oxygen
    Austria

  • Study of MC2 TCR T Cell Therapy and Epigenetic Drug Treatment for Patients with Advanced Melanoma or Head and Neck Cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Retroviral Vector Containing The Common Gamma Chain Cdna
    The Netherlands

  • Study on Extracellular Vesicles in Hematology Patients Treated with Brexucabtagene Autoleucel and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Lymphocyte adoptive therapy
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    • Idecabtagene Vicleucel
    • Axicabtagene Ciloleucel
    France

  • Study of Azithromycin Effects on Cellular Aging Markers in Healthy Adult Volunteers

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Azithromycin
    Italy

  • Study on [68Ga]NODAGA-E[c(RGDyK)]2 for Imaging Blood Vessel Growth in Patients with Chronic Ischemic Heart Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    Investigated Drugs:
    • [68GA]NODAGA-GLU(CYCLO[-ARG-GLY-ASP-D-TYR-LYS)]2
    Denmark

  • Study on Muscle Growth in Healthy Aging and Sarcopenia Patients Using Testosterone Undecanoate and Placebo

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Testosterone Undecanoate
    • Sodium Chloride
    Norway
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!